Page last updated: 2024-11-07

prednisone and Aggressive Systemic Mastocytosis

prednisone has been researched along with Aggressive Systemic Mastocytosis in 15 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research Excerpts

ExcerptRelevanceReference
" The combination of IFN-alpha and hydroxyurea is very useful and allows dosage reduction of IFN-alpha and better control of hypereosinophilia than with either agent alone."2.43Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. ( Butterfield, JH, 2005)
"Our case is the first published case of exophthalmos and eyelid edema associated with systemic mastocytosis confirmed by pathologic examination of periocular biopsies that was treated effectively with cladribine."1.43Exophthalmos, Diplopia, and Bilateral Eyelid Edema: Symptoms of Ocular Mastocytosis. ( Canioni, D; Chandesris, O; Costes, V; Frouin, E; Menjot de Champfleur, N; Mura, F; Payerols, A; Schiffmann, A; Villain, M, 2016)
"We report two unusual cases of acquired aplastic anemia (AA) in which multifocal aggregates of bone marrow mast cells fulfilled morphologic and immunophenotypic criteria for SM according to the World Health Organization 2008 classification."1.40Two cases of concomitant acquired aplastic anemia and systemic mastocytosis. ( Czuchlewski, DR; George, TI; Golardi, N; Myers, JB; Saffer, H; Sramek, JE, 2014)
"Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges."1.32Aggressive systemic mastocytosis. ( Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R, 2003)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (53.33)29.6817
2010's7 (46.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, C1
Greenberger, PA1
Papadopoulou, V1
Ioannou, S1
Levidou, G1
Variami, E1
Kouzis, P1
Siakantaris, M1
Golardi, N1
Sramek, JE1
Myers, JB1
Saffer, H1
George, TI1
Czuchlewski, DR1
Payerols, A1
Frouin, E1
Schiffmann, A1
Menjot de Champfleur, N1
Canioni, D1
Chandesris, O1
Costes, V1
Villain, M1
Mura, F1
Prabhakaran, A1
Dhaliwal, G1
Schilf, CR1
Caughey, GH1
Pile, J1
Eccersley, LR1
Hoffbrand, AV1
Rustin, MH1
McNamara, CJ1
Lamm, CG1
Stern, AW1
Smith, AJ1
Cooper, EJ1
Ullom, SW1
Campbell, GA1
Lim, KH1
Pardanani, A1
Butterfield, JH2
Li, CY1
Tefferi, A1
Ross, JJ1
Saavedra, A1
Vleugels, RA1
Liu, A1
Castells, MC1
Liu, AY1
Lowe, RC1
Levy, BD1
Katz, JT1
Loscalzo, J1
Inaoui, R1
Petit, B1
Jaccard, A1
Bertin, P1
Trèves, R1
Tolar, J1
Tope, WD1
Neglia, JP1
Marbello, L1
Anghilieri, M1
Nosari, A1
Minola, E1
Cairoli, R1
Ricci, F1
Morra, E1
Hein, MS1
Hansen, L1

Reviews

4 reviews available for prednisone and Aggressive Systemic Mastocytosis

ArticleYear
Idiopathic anaphylaxis.
    Allergy and asthma proceedings, 2019, 11-01, Volume: 40, Issue:6

    Topics: Anaphylaxis; Diagnosis, Differential; Epinephrine; Humans; Mastocytosis, Systemic; Prednisone

2019
A shocking diagnosis.
    Journal of hospital medicine, 2017, Volume: 12, Issue:2

    Topics: Acetates; Aged; Anti-Inflammatory Agents; Cyclopropanes; Diagnosis, Differential; Humans; Hypotensio

2017
Aggressive systemic mastocytosis: a case report and brief review of the literature.
    South Dakota journal of medicine, 2005, Volume: 58, Issue:3

    Topics: Aged; Antineoplastic Agents, Hormonal; Biopsy; Bone Marrow Cells; Clinical Chemistry Tests; Diagnosi

2005
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
    Acta haematologica, 2005, Volume: 114, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Cell Prolifera

2005

Other Studies

11 other studies available for prednisone and Aggressive Systemic Mastocytosis

ArticleYear
Systemic mastocytosis accompanied by a non-secretory plasma cell dyscrasia and nephrotic syndrome-level proteinuria in a 76-year-old patient.
    Acta haematologica, 2014, Volume: 131, Issue:2

    Topics: Aged; Amyloidosis; Anemia; Biopsy; Bone Marrow; Clone Cells; Coloring Agents; Congo Red; Darbepoetin

2014
Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.
    Human pathology, 2014, Volume: 45, Issue:2

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Examination; Cyclosporine; Hu

2014
Exophthalmos, Diplopia, and Bilateral Eyelid Edema: Symptoms of Ocular Mastocytosis.
    Optometry and vision science : official publication of the American Academy of Optometry, 2016, Volume: 93, Issue:11

    Topics: Administration, Oral; Diplopia; Edema; Exophthalmos; Eyelid Diseases; Glucocorticoids; Humans; Infus

2016
Paraneoplastic pemphigus associated with systemic mastocytosis.
    American journal of hematology, 2009, Volume: 84, Issue:12

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Disease Progres

2009
Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat.
    Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 2009, Volume: 21, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Cats; Exons; Female; Fetus; Mast Cells; Mastocytosis; Mastocytosis,

2009
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.
    American journal of hematology, 2009, Volume: 84, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Benzamides; Bone Marrow; Cladribine; Dioxygenases; DNA Mutational An

2009
Interactive medical case. A rash hypothesis.
    The New England journal of medicine, 2010, Jun-17, Volume: 362, Issue:24

    Topics: Acetates; Adult; Anti-Inflammatory Agents; Cromolyn Sodium; Cyclopropanes; Diarrhea; Drug Therapy, C

2010
Clinical problem-solving. A rash hypothesis.
    The New England journal of medicine, 2010, Jul-01, Volume: 363, Issue:1

    Topics: Adult; Biopsy; Blood Cell Count; Bone Marrow; Colon; Diagnosis, Differential; Diarrhea; Drug Therapy

2010
Aggressive systemic mastocytosis.
    Joint bone spine, 2003, Volume: 70, Issue:1

    Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Mye

2003
Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
    The New England journal of medicine, 2004, Feb-12, Volume: 350, Issue:7

    Topics: Acetates; Anti-Inflammatory Agents; Cyclopropanes; Drug Therapy, Combination; Humans; Infant; Leukot

2004
Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
    Haematologica, 2004, Volume: 89, Issue:9

    Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Amino Acid Substitution; Antineoplastic Combined Che

2004